Nov 4 (Reuters) - Eli Lilly ( LLY ) and Novo Nordisk
are preparing to announce new drug pricing deals with
the White House, including for their blockbuster weight loss
drugs, in return for coverage of products under Medicare,
Endpoints New reported on Tuesday, citing sources familiar with
the matter.
(Reporting by Sriparna Roy in Bengaluru)